Thu, Jan 29, 2015, 6:22 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Trius Therapeutics, Inc. (TSRX) Message Board

  • denisgodin89 denisgodin89 Mar 25, 2013 2:36 PM Flag

    Must Real All UPGRADE

    Very interresting

    Equities researchers at Aegis raised their target price on shares of Trius Therapeutics (NASDAQ: TSRX) from $14.00 to $18.00 in a report issued on Monday. The firm currently has a “buy” rating on the stock.

    Shares of Trius Therapeutics (NASDAQ: TSRX) traded down 1.97% during mid-day trading on Monday, hitting $6.852. Trius Therapeutics has a 52 week low of $4.41 and a 52 week high of $7.20. The stock’s 50-day moving average is currently $5.81. The company’s market cap is $327.9 million.

    Sentiment: Strong Buy

13.630.0000(0.00%)Sep 11 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.